S. Park and B. Mehrad, Innate Immunity to Aspergillus Species, Clinical Microbiology Reviews, vol.22, issue.4, pp.535-551, 2009.
DOI : 10.1128/CMR.00014-09

A. Mccormick, J. Loeffler, and F. Ebel, Aspergillus fumigatus: contours of an opportunistic human pathogen, Cellular Microbiology, vol.51, issue.11, pp.1535-1543, 2010.
DOI : 10.1111/j.1462-5822.2010.01517.x

H. Hebart, C. Bollinger, P. Fisch, J. Sarfati, C. Meisner et al., Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individuals and patients with hematologic malignancies, Blood, vol.100, issue.13, pp.4521-4528, 2002.
DOI : 10.1182/blood-2002-01-0265

R. Kojima, M. Kami, Y. Nannya, E. Kusumi, M. Sakai et al., Incidence of invasive aspergillosis after allogeneic hematopoietic stem cell transplantation with a reduced-intensity regimen compared with transplantation with a conventional regimen, Biology of Blood and Marrow Transplantation, vol.10, issue.9, pp.645-652, 2004.
DOI : 10.1016/j.bbmt.2004.06.003

A. Rivera, T. Hohl, and E. Pamer, Immune Responses to Aspergillus fumigatus Infections, Biology of Blood and Marrow Transplantation, vol.12, issue.1
DOI : 10.1016/j.bbmt.2005.09.007

R. Ben-­?ami, R. Lewis, and D. Kontoyiannis, Enemy of the (immunosuppressed) state: an update on the pathogenesis of Aspergillus fumigatus infection, British Journal of Haematology, vol.74, issue.Suppl. 1, pp.406-417, 2010.
DOI : 10.1111/j.1365-2141.2010.08283.x

I. Bromley and K. Donaldson, Binding of Aspergillus fumigatus spores to lung epithelial cells and basement membrane proteins: relevance to the asthmatic lung., Thorax, vol.51, issue.12, pp.1203-1209, 1996.
DOI : 10.1136/thx.51.12.1203

J. Camuset, A. Lavolé, M. Wislez, A. Khalil, A. Bellocq et al., Infections aspergillaires broncho-pulmonaires du sujet non immunod??prim??, Revue de Pneumologie Clinique, vol.63, issue.3, pp.155-166, 2007.
DOI : 10.1016/S0761-8417(07)90120-0

A. Soubani and P. Chandrasekar, The Clinical Spectrum of Pulmonary Aspergillosis, Chest, vol.121, issue.6
DOI : 10.1378/chest.121.6.1988

K. Marr, R. Carter, M. Boeckh, P. Martin, and L. Corey, Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors):4358?4366. 12. Shoham S, Levitz SM. The immune response to fungal infections, Blood. 15 déc Br. J. Haematol. juin, vol.100129, issue.135, pp.569-582, 2002.

M. Kousha, R. Tadi, and A. Soubani, Pulmonary aspergillosis: a clinical review, European Respiratory Review, vol.20, issue.121, pp.156-174, 2011.
DOI : 10.1183/09059180.00001011

D. Denning, K. Riniotis, R. Dobrashian, and H. Sambatakou, Chronic Cavitary and Fibrosing Pulmonary and Pleural Aspergillosis: Case Series, Proposed Nomenclature Change, and Review, Clinical Infectious Diseases, vol.37, issue.s3, pp.265-280, 2003.
DOI : 10.1086/376526

URL : http://cid.oxfordjournals.org/cgi/content/short/37/Supplement_3/S265

M. Uffredi, G. Mangiapan, J. Cadranel, and G. Kac, Significance of Aspergillus fumigatus Isolation from Respiratory Specimens of Nongranulocytopenic Patients, European Journal of Clinical Microbiology & Infectious Diseases, vol.22, issue.8, pp.457-462, 2003.
DOI : 10.1007/s10096-003-0970-y

J. Saraceno, D. Phelps, T. Ferro, R. Futerfas, and D. Schwartz, Chronic Necrotizing Pulmonary Aspergillosis*, Chest, vol.112, issue.2, pp.541-548, 1997.
DOI : 10.1378/chest.112.2.541

O. Lortholary, J. Gangneux, K. Sitbon, B. Lebeau, D. Monbrison et al., Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005???2007), Clinical Microbiology and Infection, vol.17, issue.12, pp.1882-1889, 2011.
DOI : 10.1111/j.1469-0691.2011.03548.x

URL : https://hal.archives-ouvertes.fr/hal-00680990

Y. Nivoix, M. Velten, V. Letscher-­?bru, A. Moghaddam, S. Natarajan-­?amé et al., Factors Associated with Overall and Attributable Mortality in Invasive Aspergillosis, Clinical Infectious Diseases, vol.47, issue.9, pp.1176-1184, 2008.
DOI : 10.1086/592255

D. Pauw, B. Walsh, T. Donnelly, J. Stevens, D. Edwards et al., Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group, Clinical Infectious Diseases, vol.46, issue.12, pp.1813-1821, 2008.
DOI : 10.1086/588660

D. Paterson and N. Singh, Invasive Aspergillosis in Transplant Recipients, Medicine, vol.78, issue.2, pp.123-138, 1999.
DOI : 10.1097/00005792-199903000-00003

S. Blumental, R. Mouy, N. Mahlaoui, M. Bougnoux, M. Debré et al., Invasive Mold Infections in Chronic Granulomatous Disease: A 25-Year Retrospective Survey, Clinical Infectious Diseases, vol.53, issue.12, pp.159-169, 2011.
DOI : 10.1093/cid/cir731

. Comme-précédemment-rapporté, la présence de nodules avec halo était plus fréquente chez les patients neutropéniques (44% versus 11%) et les aspects d'arbre en bourgeon étaient plus fréquents chez les patients ayant des leucocytes > 500

S. Park and B. Mehrad, Innate Immunity to Aspergillus Species, Clinical Microbiology Reviews, vol.22, issue.4, pp.535-551, 2009.
DOI : 10.1128/CMR.00014-09

A. Mccormick, J. Loeffler, and F. Ebel, Aspergillus fumigatus: contours of an opportunistic human pathogen, Cellular Microbiology, vol.51, issue.11, pp.1535-1543, 2010.
DOI : 10.1111/j.1462-5822.2010.01517.x

H. Hebart, C. Bollinger, P. Fisch, J. Sarfati, C. Meisner et al., Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individuals and patients with hematologic malignancies, Blood, vol.100, issue.13, pp.4521-4528, 2002.
DOI : 10.1182/blood-2002-01-0265

R. Kojima, M. Kami, Y. Nannya, E. Kusumi, M. Sakai et al., Incidence of invasive aspergillosis after allogeneic hematopoietic stem cell transplantation with a reduced-intensity regimen compared with transplantation with a conventional regimen, Biology of Blood and Marrow Transplantation, vol.10, issue.9, pp.645-652, 2004.
DOI : 10.1016/j.bbmt.2004.06.003

A. Rivera, T. Hohl, and E. Pamer, Immune Responses to Aspergillus fumigatus Infections, Biology of Blood and Marrow Transplantation, vol.12, issue.1
DOI : 10.1016/j.bbmt.2005.09.007

R. Ben-­?ami, R. Lewis, and D. Kontoyiannis, Enemy of the (immunosuppressed) state: an update on the pathogenesis of Aspergillus fumigatus infection, British Journal of Haematology, vol.74, issue.Suppl. 1, pp.406-417, 2010.
DOI : 10.1111/j.1365-2141.2010.08283.x

I. Bromley and K. Donaldson, Binding of Aspergillus fumigatus spores to lung epithelial cells and basement membrane proteins: relevance to the asthmatic lung., Thorax, vol.51, issue.12, pp.1203-1209, 1996.
DOI : 10.1136/thx.51.12.1203

J. Camuset, A. Lavolé, M. Wislez, A. Khalil, A. Bellocq et al., Infections aspergillaires broncho-pulmonaires du sujet non immunod??prim??, Revue de Pneumologie Clinique, vol.63, issue.3, pp.155-166, 2007.
DOI : 10.1016/S0761-8417(07)90120-0

A. Soubani and P. Chandrasekar, The Clinical Spectrum of Pulmonary Aspergillosis, Chest, vol.121, issue.6
DOI : 10.1378/chest.121.6.1988

K. Marr, R. Carter, M. Boeckh, P. Martin, and L. Corey, Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors):4358?4366. 12. Shoham S, Levitz SM. The immune response to fungal infections, Blood. 15 déc Br. J. Haematol. juin, vol.100129, issue.135, pp.569-582, 2002.

M. Kousha, R. Tadi, and A. Soubani, Pulmonary aspergillosis: a clinical review, European Respiratory Review, vol.20, issue.121, pp.156-174, 2011.
DOI : 10.1183/09059180.00001011

D. Denning, K. Riniotis, R. Dobrashian, and H. Sambatakou, Chronic Cavitary and Fibrosing Pulmonary and Pleural Aspergillosis: Case Series, Proposed Nomenclature Change, and Review, Clinical Infectious Diseases, vol.37, issue.s3, pp.265-280, 2003.
DOI : 10.1086/376526

M. Uffredi, G. Mangiapan, J. Cadranel, and G. Kac, Significance of Aspergillus fumigatus Isolation from Respiratory Specimens of Nongranulocytopenic Patients, European Journal of Clinical Microbiology & Infectious Diseases, vol.22, issue.8, pp.457-462, 2003.
DOI : 10.1007/s10096-003-0970-y

J. Saraceno, D. Phelps, T. Ferro, R. Futerfas, and D. Schwartz, Chronic Necrotizing Pulmonary Aspergillosis*, Chest, vol.112, issue.2, pp.541-548, 1997.
DOI : 10.1378/chest.112.2.541

O. Lortholary, J. Gangneux, K. Sitbon, B. Lebeau, D. Monbrison et al., Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005???2007), Clinical Microbiology and Infection, vol.17, issue.12, pp.1882-1889, 2011.
DOI : 10.1111/j.1469-0691.2011.03548.x

URL : https://hal.archives-ouvertes.fr/hal-00680990

Y. Nivoix, M. Velten, V. Letscher-­?bru, A. Moghaddam, S. Natarajan-­?amé et al., Factors Associated with Overall and Attributable Mortality in Invasive Aspergillosis, Clinical Infectious Diseases, vol.47, issue.9, pp.1176-1184, 2008.
DOI : 10.1086/592255

D. Pauw, B. Walsh, T. Donnelly, J. Stevens, D. Edwards et al., Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group, Clinical Infectious Diseases, vol.46, issue.12, pp.1813-1821, 2008.
DOI : 10.1086/588660

D. Paterson and N. Singh, Invasive Aspergillosis in Transplant Recipients, Medicine, vol.78, issue.2, pp.123-138, 1999.
DOI : 10.1097/00005792-199903000-00003

S. Blumental, R. Mouy, N. Mahlaoui, M. Bougnoux, M. Debré et al., Invasive mold infections in chronic granulomatous disease: a 25-­?year retrospective survey):e159?169. dominant STAT3 deficiency and hyper-­?IgE syndrome: molecular, cellular, and clinical features from a French national survey, Clin. Infect. Dis. déc Medicine, vol.5391, issue.124, pp.1-19, 2011.

F. Ader, S. Nseir, B. Guery, I. Tillie-­?leblond, K. Marr et al., Acute invasive pulmonary aspergillosis in chronic lung disease-­?-­?a review] Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-­?2006: overview of the Transplant-­?Associated Infection Surveillance Network (TRANSNET) Database, 6S11?16S20. 27. Kontoyiannis DP1091?1100. 28. Pagano L, The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-­? 2004 study, pp.1068-1075, 2006.

G. Maschmeyer, A. Haas, O. Cornely, A. Wald, W. Leisenring et al., Invasive Aspergillosis, 827?833. 32. Neofytos D al. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry, 1997.
DOI : 10.2165/00003495-200767110-00004

S. Ascioglu, J. Rex, D. Pauw, B. Bennett, J. Bille et al., Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America, 327?360. 35. A. J. Barnes DWD. Aspergilli -­? significance as pathogens, 1993.

D. Denning, Aspergillosis: diagnosis and treatment, International Journal of Antimicrobial Agents, vol.6, issue.3, pp.161-168, 1996.
DOI : 10.1016/0924-8579(95)00042-9

J. Horvath and S. Dummer, The use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis, The American Journal of Medicine, vol.100, issue.2, pp.171-178, 1996.
DOI : 10.1016/S0002-9343(97)89455-7

H. Levy, D. Horak, B. Tegtmeier, S. Yokota, and S. Forman, The value of bronchoalveolar lavage and bronchial washings in the diagnosis of invasive pulmonary aspergillosis, Respiratory Medicine, vol.86, issue.3, pp.243-248, 1992.
DOI : 10.1016/S0954-6111(06)80062-4

J. Maertens, V. Maertens, K. Theunissen, W. Meersseman, P. Meersseman et al., Bronchoalveolar Lavage Fluid Galactomannan for the Diagnosis of Invasive Pulmonary Aspergillosis in Patients with Hematologic Diseases, Clinical Infectious Diseases, vol.49, issue.11, pp.1688-1693, 2009.
DOI : 10.1086/647935

C. Lass-­?flörl, G. Resch, D. Nachbaur, A. Mayr, G. Gastl et al., The Value of Computed Tomography-Guided Percutaneous Lung Biopsy for Diagnosis of Invasive Fungal Infection in Immunocompromised Patients, Clinical Infectious Diseases, vol.45, issue.7, pp.101-104, 2007.
DOI : 10.1086/521245

C. Pfeiffer, J. Fine, and N. Safdar, Diagnosis of Invasive Aspergillosis Using a Galactomannan Assay: A Meta-Analysis, Clinical Infectious Diseases, vol.42, issue.10, pp.1417-1727, 2006.
DOI : 10.1086/503427

A. Bergeron, A. Belle, A. Sulahian, C. Lacroix, S. Chevret et al., Contribution of Galactomannan Antigen Detection in BAL to the Diagnosis of Invasive Pulmonary Aspergillosis in Patients With Hematologic Malignancies, Chest, vol.137, issue.2, pp.410-415, 2010.
DOI : 10.1378/chest.09-0701

P. Verweij, J. Latgé, A. Rijs, W. Melchers, D. Pauw et al., Comparison of antigen detection and PCR assay using bronchoalveolar lavage fluid for diagnosing invasive pulmonary aspergillosis in patients receiving treatment for hematological malignancies, J. Clin. Microbiol. déc, vol.33, issue.12, pp.3150-3153, 1995.

M. Sanguinetti, B. Posteraro, L. Pagano, G. Pagliari, L. Fianchi et al., Comparison of Real-Time PCR, Conventional PCR, and Galactomannan Antigen Detection by Enzyme-Linked Immunosorbent Assay Using Bronchoalveolar Lavage Fluid Samples from Hematology Patients for Diagnosis of Invasive Pulmonary Aspergillosis, Journal of Clinical Microbiology, vol.41, issue.8, pp.3922-3925, 2003.
DOI : 10.1128/JCM.41.8.3922-3925.2003

B. Musher, D. Fredricks, W. Leisenring, S. Balajee, C. Smith et al., Aspergillus Galactomannan Enzyme Immunoassay and Quantitative PCR for Diagnosis of Invasive Aspergillosis with Bronchoalveolar Lavage Fluid, Journal of Clinical Microbiology, vol.42, issue.12, pp.5517-5522, 2004.
DOI : 10.1128/JCM.42.12.5517-5522.2004

S. Galactomannan-kimura, S. Odawara, J. Aoki, T. Yamakura, M. Takeuchi et al., fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis Detection of sputum Aspergillus galactomannan for diagnosis of invasive pulmonary aspergillosis in haematological patients Contribution of the (1-­?-­?>3)-­?beta-­?D-­?glucan assay for diagnosis of invasive fungal infections, 448?457. 48, pp.463-470, 2003.

R. Hachem, D. Kontoyiannis, R. Chemaly, Y. Jiang, R. Reitzel et al., Utility of Galactomannan Enzyme Immunoassay and (1,3) ??-D-Glucan in Diagnosis of Invasive Fungal Infections: Low Sensitivity for Aspergillus fumigatus Infection in Hematologic Malignancy Patients, Journal of Clinical Microbiology, vol.47, issue.1, pp.129-133, 2009.
DOI : 10.1128/JCM.00506-08

T. Obayashi, K. Negishi, T. Suzuki, and N. Funata, Reappraisal of the serum (1-­?-­?>3)-­?beta-­?D-­? glucan assay for the diagnosis of invasive fungal infections-­?-­?a study based on autopsy cases from 6 years, Clin. Infect. Dis. 15 juin, vol.46, issue.52, 2008.

S. Koo, J. Bryar, J. Page, L. Baden, and F. Marty, ???Glucan Assay for Invasive Fungal Disease, Clinical Infectious Diseases, vol.49, issue.11, pp.1650-1659, 2009.
DOI : 10.1086/647942

C. Mengoli, M. Cruciani, R. Barnes, J. Loeffler, and J. Donnelly, Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis, The Lancet Infectious Diseases, vol.9, issue.2, pp.89-96, 2009.
DOI : 10.1016/S1473-3099(09)70019-2

S. Bretagne, J. Costa, E. Bart-­?delabesse, N. Dhédin, C. Rieux et al., Comparison of Serum Galactomannan Antigen Detection and Competitive Polymerase Chain Reaction for Diagnosing Invasive Aspergillosis, Clinical Infectious Diseases, vol.26, issue.6, pp.1407-1412, 1998.
DOI : 10.1086/516343

S. Bretagne, Primary diagnostic approaches of invasive aspergillosis ??? molecular testing, Medical Mycology, vol.49, issue.S1, pp.48-53, 2011.
DOI : 10.3109/13693786.2010.508186

C. Cordonnier, P. Ribaud, R. Herbrecht, N. Milpied, D. Valteau-­?couanet et al., Prognostic Factors for Death Due to Invasive Aspergillosis after Hematopoietic Stem Cell Transplantation: A 1-Year Retrospective Study of Consecutive Patients at French Transplantation Centers, Clinical Infectious Diseases, vol.42, issue.7, pp.955-963, 2006.
DOI : 10.1086/500934

A. Upton, K. Kirby, P. Carpenter, M. Boeckh, and K. Marr, Invasive Aspergillosis following Hematopoietic Cell Transplantation: Outcomes and Prognostic Factors Associated with Mortality, Clinical Infectious Diseases, vol.44, issue.4, pp.531-540, 2007.
DOI : 10.1086/510592

A. Bergeron, R. Porcher, J. Menotti, J. Poirot, K. Chagnon et al., Prospective Evaluation of Clinical and Biological Markers To Predict the Outcome of Invasive Pulmonary Aspergillosis in Hematological Patients, Journal of Clinical Microbiology, vol.50, issue.3, pp.823-830, 2012.
DOI : 10.1128/JCM.00750-11

URL : https://hal.archives-ouvertes.fr/hal-00818504

G. Salmeron, R. Porcher, A. Bergeron, M. Robin, P. De-latour et al., Persistent poor long-term prognosis of allogeneic hematopoietic stem cell transplant recipients surviving invasive aspergillosis, Haematologica, vol.97, issue.9, pp.1357-1363, 2012.
DOI : 10.3324/haematol.2011.058255

R. Herbrecht, D. Denning, T. Patterson, J. Bennett, R. Greene et al., Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis, New England Journal of Medicine, vol.347, issue.6
DOI : 10.1056/NEJMoa020191

J. Wingard, P. Ribaud, H. Schlamm, and R. Herbrecht, Changes in causes of death over time after treatment for invasive aspergillosis, Cancer, vol.44, issue.10, pp.2309-2312, 2008.
DOI : 10.1002/cncr.23441

L. Chai, B. Kullberg, E. Johnson, S. Teerenstra, L. Khin et al., Early Serum Galactomannan Trend as a Predictor of Outcome of Invasive Aspergillosis, Journal of Clinical Microbiology, vol.50, issue.7, pp.2330-2336, 2012.
DOI : 10.1128/JCM.06513-11

S. Nouér, M. Nucci, N. Kumar, M. Grazziutti, B. Barlogie et al., Earlier Response Assessment in Invasive Aspergillosis Based on the Kinetics of Serum Aspergillus Galactomannan: Proposal for a New Definition, Clinical Infectious Diseases, vol.53, issue.7, pp.671-676, 2011.
DOI : 10.1093/cid/cir441

F. Boutboul, C. Alberti, T. Leblanc, A. Sulahian, E. Gluckman et al., Invasive Aspergillosis in Allogeneic Stem Cell Transplant Recipients: Increasing Antigenemia Is Associated with Progressive Disease, Clinical Infectious Diseases, vol.34, issue.7, pp.939-943, 2002.
DOI : 10.1086/339324

J. Maertens, K. Buvé, K. Theunissen, W. Meersseman, E. Verbeken et al., Galactomannan serves as a surrogate endpoint for outcome of pulmonary invasive aspergillosis in neutropenic hematology patients, Cancer, vol.46, issue.suppl 1, pp.355-362, 2009.
DOI : 10.1002/cncr.24022

. J. Engl, T. Walsh, H. Teppler, G. Donowitz, J. Maertens et al., 11 mars Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever, N. Engl. J. Med. 30 sept N. Engl. J. Med. 24 janv, vol.340351346, issue.70144, pp.225-234, 1999.

C. Cordonnier, C. Pautas, S. Maury, A. Vekhoff, H. Farhat et al., Empirical versus preemptive antifungal therapy for high-­?risk, febrile, neutropenic patients: a randomized, controlled trial):1042?1051. 73. Falagas ME, Vardakas KZ. Liposomal amphotericin B as antifungal prophylaxis in bone marrow transplant patients Randomized, double-­?blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation, 299?300. 74, pp.5111-5118, 2006.

. J. Engl and . Med, 25 janv, 2007.

. Al, Posaconazole or fluconazole for prophylaxis in severe graft-­?versus-­?host disease, 335?347. 78. Cordonnier C, Rovira M, Maertens J, 2007.

W. Hope and D. Denning, Invasive aspergillosis: current and future challenges in diagnosis and therapy, Clinical Microbiology and Infection, vol.10, issue.1, pp.2-4, 2004.
DOI : 10.1111/j.1469-0691.2004.00809.x

E. Johnson, A. Szekely, and D. Warnock, In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi, Journal of Antimicrobial Chemotherapy, vol.42, issue.6, pp.741-745, 1998.
DOI : 10.1093/jac/42.6.741

B. Segal, R. Herbrecht, D. Stevens, L. Ostrosky-­?zeichner, J. Sobel et al., Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria, Clinical Infectious Diseases, vol.47, issue.5, pp.674-683, 2008.
DOI : 10.1086/590566

J. Kuhlman, E. Fishman, and S. Siegelman, Invasive pulmonary aspergillosis in acute leukemia: characteristic findings on CT, the CT halo sign, and the role of CT in early diagnosis., Radiology, vol.157, issue.3, pp.611-614, 1985.
DOI : 10.1148/radiology.157.3.3864189

J. Austin, N. Müller, P. Friedman, D. Hansell, D. Naidich et al., Glossary of terms for CT of the lungs: recommendations of the Nomenclature Committee of the Fleischner Society., Radiology, vol.200, issue.2, pp.327-331, 1996.
DOI : 10.1148/radiology.200.2.8685321

D. Caillot, J. Couaillier, A. Bernard, O. Casasnovas, D. Denning et al., Increasing Volume and Changing Characteristics of Invasive Pulmonary Aspergillosis on Sequential Thoracic Computed Tomography Scans in Patients With Neutropenia, Journal of Clinical Oncology, vol.19, issue.1, pp.253-259, 2001.
DOI : 10.1200/JCO.2001.19.1.253

S. Georgiadou, N. Sipsas, E. Marom, and D. Kontoyiannis, The Diagnostic Value of Halo and Reversed Halo Signs for Invasive Mold Infections in Compromised Hosts, Clinical Infectious Diseases, vol.52, issue.9, pp.1144-1155, 2011.
DOI : 10.1093/cid/cir122

R. Greene, H. Schlamm, J. Oestmann, P. Stark, C. Durand et al., Imaging Findings in Acute Invasive Pulmonary Aspergillosis: Clinical Significance of the Halo Sign, Clinical Infectious Diseases, vol.44, issue.3, pp.373-379, 2007.
DOI : 10.1086/509917

M. Nucci, S. Nouér, M. Grazziutti, N. Kumar, B. Barlogie et al., Probable Invasive Aspergillosis without Prespecified Radiologic Findings: Proposal for Inclusion of a New Category of Aspergillosis and Implications for Studying Novel Therapies, Clinical Infectious Diseases, vol.51, issue.11, pp.1273-1280, 2010.
DOI : 10.1086/657065

A. Bergeron, R. Porcher, A. Sulahian, D. Bazelaire, C. Chagnon et al., The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies, Blood, vol.119, issue.8, pp.1831-1837, 2012.
DOI : 10.1182/blood-2011-04-351601

URL : https://hal.archives-ouvertes.fr/hal-00818508

Y. Lee, Y. Choi, K. Lee, S. Jeon, C. Park et al., CT halo sign: the spectrum of pulmonary diseases, The British Journal of Radiology, vol.78, issue.933, pp.862-865, 2005.
DOI : 10.1259/bjr/77712845

F. Forghieri, L. Potenza, M. Morselli, M. Maccaferri, L. Pedrazzi et al., Organising pneumonia mimicking invasive fungal disease in patients with leukaemia, European Journal of Haematology, vol.88, issue.1, pp.76-82, 2010.
DOI : 10.1111/j.1600-0609.2010.01427.x

M. Milito, D. Kontoyiannis, R. Lewis, P. Liu, O. Mawlawi et al., Influence of host immunosuppression on CT findings in invasive pulmonary aspergillosis, Medical Mycology, vol.48, issue.6, pp.817-823, 2010.
DOI : 10.3109/13693780903514872

D. Escuissato, E. Gasparetto, E. Marchiori, G. Rocha, M. Inoue et al., Pulmonary infections after bone marrow transplantation: high-­?resolution CT findings in 111 patients Pathophysiology of pulmonary aspergillosis, 608?615. 94. Shibuya K, pp.138-145, 2004.

M. Stanzani, G. Battista, C. Sassi, R. Lewis, G. Tolomelli et al., Computed tomographic pulmonary angiography for diagnosis of invasive mold diseases in patients with hematological malignancies Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-­?year period (1989-­?2003) Differences in patterns of infection and inflammation for corticosteroid treatment and chemotherapy in experimental invasive pulmonary aspergillosis, ):610?616. 96. Chamilos):986?989. 97, pp.494-503, 2005.

J. Berenguer, M. Allende, J. Lee, K. Garrett, C. Lyman et al., Pathogenesis of pulmonary aspergillosis. Granulocytopenia versus cyclosporine and methylprednisolone-­? induced immunosuppression Chest computed tomography of late invasive aspergillosis after allogeneic hematopoietic stem cell transplantation, 1079?1086. 99. Kojima R, pp.506-511, 1995.

T. Franquet, N. Müller, A. Oikonomou, and J. Flint, Aspergillus Infection of the Airways, Journal of Computer Assisted Tomography, vol.28, issue.1, pp.10-16, 2004.
DOI : 10.1097/00004728-200401000-00002

P. Logan, S. Primack, R. Miller, and N. Müller, Invasive aspergillosis of the airways: radiographic, CT, and pathologic findings., Radiology, vol.193, issue.2, pp.383-388, 1994.
DOI : 10.1148/radiology.193.2.7972747

T. Hartman, S. Primack, K. Lee, S. Swensen, and N. Müller, CT of bronchial and bronchiolar diseases., RadioGraphics, vol.14, issue.5, pp.991-1003, 1994.
DOI : 10.1148/radiographics.14.5.7991828

T. Franquet, N. Müller, A. Giménez, P. Guembe, J. De-la-torre et al., Spectrum of Pulmonary Aspergillosis: Histologic, Clinical, and Radiologic Findings, RadioGraphics, vol.21, issue.4, pp.825-837, 2001.
DOI : 10.1148/radiographics.21.4.g01jl03825

N. Almyroudis, D. Kontoyiannis, K. Sepkowitz, B. Depauw, T. Walsh et al., Issues Related to the Design and Interpretation of Clinical Trials of Salvage Therapy for Invasive Mold Infection, Clinical Infectious Diseases, vol.43, issue.11, pp.1449-1455, 2006.
DOI : 10.1086/508455

T. Walsh, I. Raad, T. Patterson, P. Chandrasekar, G. Donowitz et al., Treatment of Invasive Aspergillosis with Posaconazole in Patients Who Are Refractory to or Intolerant of Conventional Therapy: An Externally Controlled Trial, Clinical Infectious Diseases, vol.44, issue.1, pp.2-12, 2007.
DOI : 10.1086/508774

J. Maertens, K. Theunissen, G. Verhoef, and J. Van-eldere, False-Positive Aspergillus Galactomannan Antigen Test Results, Clinical Infectious Diseases, vol.39, issue.2, pp.289-290, 2004.
DOI : 10.1086/422151

URL : http://cid.oxfordjournals.org/cgi/content/short/39/2/289-a

I. Raad, H. Hanna, M. Boktour, Y. Jiang, H. Torres et al., Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin, Leukemia, vol.36, issue.3, pp.496-503, 2008.
DOI : 10.1086/514341

D. Caillot, A. Thiébaut, R. Herbrecht, D. Botton, S. Pigneux et al., Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies, Cancer, vol.187, issue.12, pp.2740-2746, 2007.
DOI : 10.1002/cncr.23109

D. Caillot, V. Latrabe, A. Thiébaut, R. Herbrecht, D. Botton et al., Computer tomography in pulmonary invasive aspergillosis in hematological patients with neutropenia: An useful tool for diagnosis and assessment of outcome in clinical trials, European Journal of Radiology, vol.74, issue.3, pp.172-175, 2010.
DOI : 10.1016/j.ejrad.2009.05.058

W. Gefter, S. Albelda, G. Talbot, S. Gerson, P. Cassileth et al., Invasive pulmonary aspergillosis and acute leukemia. Limitations in the diagnostic utility of the air crescent sign., Radiology, vol.157, issue.3, pp.605-610, 1985.
DOI : 10.1148/radiology.157.3.4059547

S. Abramson, The Air Crescent Sign, Radiology, vol.218, issue.1, pp.230-232, 2001.
DOI : 10.1148/radiology.218.1.r01ja19230

G. Woods, M. Miceli, M. Grazziutti, W. Zhao, B. Barlogie et al., Serum Aspergillus galactomannan antigen values strongly correlate with outcome of invasive aspergillosis, Cancer, vol.159, issue.4, pp.830-834, 2007.
DOI : 10.1002/cncr.22863

R. Team, R Foundation for Statistical Computing R: a language and Environment for Statistical Computing